Elipse Balloon from Allurion Technologies
Boston-based Allurion Technologies has raised $27 million in Series C funding to commercialize its intragastric balloon device. Contributors included current investor Romulus Capital, along with Cogepa Investments and IDO Investments.
“The funding…
Source: medcitynews.com – Read more
Y chromosome loss creates hidden cancer vulnerability in men
A study initiated by a University of Arizona Cancer Center physician-scientist Dr. Dan Theodorescu revealed that the loss of the Y chromosome in men’s body
